RECOMBINETICS, INC

Profile

Company Names

RECOMBINETICS, INC

Addresses

1246 UNIVERSITY AVENUE WEST, SUITE 301, ST. PAUL, MN 55104

1246 UNIVERSITY AVENUE WEST, #301, ST. PAUL, MN 55104

1246 UNIVERSITY AVE W, SUITE 301, ST PAUL, MN 55104

Phone Numbers

612-727-2000
612 727 2000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

MINNESOTA

Total Amount Raised:

$64,591,019.00

Number of Funding Rounds:

11
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
11
2018-08-20 
$33,510,969.00 
$33,510,969.00 
$0.00 
Equity 
10
2017-09-22 
$82,500.00 
$18,150,000.00 
$18,067,500.00 
Equity 
9
2017-09-14 
$6,361,560.00 
$18,150,000.00 
$11,788,440.00 
Equity 
8
2017-02-14 
$6,982,500.00 
$8,268,750.00 
$1,286,250.00 
Debt 
7
2016-10-20 
$7,684,275.00 
$27,604,001.00 
$19,919,726.00 
 
6
2016-07-27 
$630,000.00 
$3,688,820.00 
$3,058,820.00 
Equity 
5
2015-06-26 
$5,663,165.00 
$10,000,000.00 
$4,336,835.00 
Equity 
4
2015-06-25 
$2,770,250.00 
$10,000,000.00 
$7,229,750.00 
Equity 
3
2014-08-11 
$540,800.00 
$3,000,000.00 
$2,459,200.00 
Equity 
2
2013-07-22 
$35,000.00 
$4,000,000.00 
$3,965,000.00 
Equity 
1
2012-03-01 
$330,000.00 
$2,000,000.00 
$1,670,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
ABERLE 
EXECUTIVE OFFICER
MITCH 
 
ABRAHAMSEN 
DIRECTOR
MITCHELL 
 
ABRAHAMSEN, PH.D. 
DIRECTOR, EXECUTIVE OFFICER
MITCHELL 
 
ABRAMHAMSEN, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
JERRY 
 
ARNDT 
DIRECTOR
JOHN 
 
BURTIS 
EXECUTIVE OFFICER
JOHN 
F. 
CAMERON 
EXECUTIVE OFFICER
DANIEL 
F. 
CARLSON, PH.D. 
EXECUTIVE OFFICER
KYLE 
 
DAWLEY 
EXECUTIVE OFFICER
SCOTT 
C. 
FAHRENKRUG 
EXECUTIVE OFFICER, DIRECTOR
SCOTT 
CHRISTOPHER 
FAHRENKRUG 
EXECUTIVE OFFICER, DIRECTOR
SCOTT 
C. 
FAHRENKRUG, PH.D. 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
BILL 
 
FARRELL 
DIRECTOR
IAN 
R. 
FRIENDLY 
EXECUTIVE OFFICER, DIRECTOR
PERRY 
B. 
HACKET, PH.D. 
DIRECTOR
PERRY 
B. 
HACKETT, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
PETER 
 
HAJAS 
DIRECTOR
CLIFF 
 
HOFFMAN 
DIRECTOR
DOUGLAS 
 
KEETH 
DIRECTOR
JIM 
 
KILMAN 
DIRECTOR
WENDELL 
 
KING 
DIRECTOR
MARK 
 
KROLL, PH.D. 
DIRECTOR
TAMMY 
 
LEE 
EXECUTIVE OFFICER
WILLIAM 
 
MCKNIGHT, JR. 
DIRECTOR
GREG 
 
MELSEN 
DIRECTOR
PAUL 
 
OLSON, ED.D. 
DIRECTOR
SCOTT 
 
RATHGABER 
DIRECTOR
TAD 
 
SONSTEGARD, PH.D. 
EXECUTIVE OFFICER
TAMMY 
LEE 
STANOCH 
EXECUTIVE OFFICER
TAMMY 
LEE 
STANOCK 
EXECUTIVE OFFICER
ROBERT 
 
SWITZ 
DIRECTOR
MARK 
 
WALTON, PH.D. 
EXECUTIVE OFFICER
JUSTIN 
 
ZENANKO 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2016-10-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-20 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-14 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2016-10-20 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-02-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-07-27 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-08-11 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-07-22 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2012-03-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
VAN CLEMENS + CO. INCORPORATED
VAN CLEMENS + CO. INCORPORATED
VAN CLEMENS + CO. INC.
N/A
NONE
NONE
EMERGENT FINANCIAL
VAN CLEMENS + CO INC
NONE
NONE